Exponent (NASDAQ:EXPO) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Exponent (NASDAQ:EXPO - Get Free Report) issued its quarterly earnings results on Thursday. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04, Zacks reports. The business had revenue of $132.87 million for the quarter, compared to the consensus estimate of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.24%. The firm's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.57 EPS.Exponent Stock Performance7 best fintech ETFs to buy nowNASDAQ:EXPO traded down $0.63 on Friday, hitting $68.33. 949,090 shares of the stock were exchanged, compared to its average volume of 275,776. The stock has a market capitalization of $3.47 billion, a price-to-earnings ratio of 34.17 and a beta of 0.90. Exponent has a 52 week low of $63.81 and a 52 week high of $115.75. The company's 50-day moving average price is $74.71 and its 200 day moving average price is $80.32. Exponent Dividend AnnouncementThe business also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, September 5th. This represents a $1.20 annualized dividend and a yield of 1.8%. Exponent's dividend payout ratio is 60.00%. Insiders Place Their BetsHow to Buy OpenAI Stock: A GuideIn other news, VP John Pye sold 2,000 shares of the company's stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the completion of the sale, the vice president directly owned 29,204 shares of the company's stock, valued at $2,228,849.28. This represents a 6.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Joseph Rakow sold 1,573 shares of the company's stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. In the last three months, insiders sold 6,267 shares of company stock valued at $489,120. 1.60% of the stock is currently owned by insiders. Hedge Funds Weigh In On ExponentAn institutional investor recently bought a new position in Exponent stock. United Services Automobile Association purchased a new position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 3,282 shares of the business services provider's stock, valued at approximately $270,000. Hedge funds and other institutional investors own 92.37% of the company's stock. Exponent Company Profile (Get Free Report)How to Calculate Moving Average; How it Helps in Stock SelectionExponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.See AlsoFive stocks we like better than ExponentWhy Understanding Call Option Volume is Essential to Successful Options TradingBitcoin and Dividends: A Winning Combo in These 3 ETFsFind and Profitably Trade Stocks at 52-Week LowsIs PG&E an AI Power Play? Why Options Traders Are Betting BigThe Role Economic Reports Play in a Successful Investment StrategyMarketBeat Week in Review – 07/28 - 08/01This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Exponent Right Now?Before you consider Exponent, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here